These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 16899961

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The effect of aspirin on hemorheological parameters of patients with diabetic retinopathy.
    Vekasi J, Koltai K, Gaal V, Toth A, Juricskay I, Kesmarky G.
    Clin Hemorheol Microcirc; 2008; 39(1-4):385-9. PubMed ID: 18503149
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [Porphyria cutanea tarda, hemodialysis and HCV hepatopathy].
    Muray S, Casanova JM, Marco MP, Craver L, Martín M, Fernández E.
    Nefrologia; 2002; 22(6):570-3. PubMed ID: 12516291
    [Abstract] [Full Text] [Related]

  • 51. Porphyria cutanea tarda and chronic lymphoid leukemia.
    Remenyik E, Ujj G, Kiss A, Kószó F, Horkay I.
    Photodermatol Photoimmunol Photomed; 1996 Aug; 12(4):180-2. PubMed ID: 9017795
    [Abstract] [Full Text] [Related]

  • 52. The effect of blood glucose levels on hemorheological parameters, platelet activation and aggregation in oral glucose tolerance tests.
    Koltai K, Feher G, Kesmarky G, Keszthelyi Z, Czopf L, Toth K.
    Clin Hemorheol Microcirc; 2006 Aug; 35(4):517-25. PubMed ID: 17148851
    [Abstract] [Full Text] [Related]

  • 53. Long-standing changes in the urinary profile of porphyrin isomers after clinical remission of porphyria cutanea tarda.
    To-Figueras J, Ozalla D, Mateu CH.
    Ann Clin Lab Sci; 2003 Aug; 33(3):251-6. PubMed ID: 12956438
    [Abstract] [Full Text] [Related]

  • 54. Porphyria cutanea tarda in pregnancy: a case report.
    Aziz Ibrahim A, Esen UI.
    J Obstet Gynaecol; 2004 Aug; 24(5):574-5. PubMed ID: 15369945
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Iron overload and cutaneous disease: an emphasis on clinicopathological correlations.
    Englander L, Friedman A.
    J Drugs Dermatol; 2010 Jun; 9(6):719-22. PubMed ID: 20645540
    [No Abstract] [Full Text] [Related]

  • 58. Hemorheological disorders in patients with type 1 or 2 diabetes mellitus and foot gangrene.
    Mantskava M, Momtselidze N, Pargalava N, Mchedlishvili G.
    Clin Hemorheol Microcirc; 2006 Jun; 35(1-2):307-10. PubMed ID: 16899949
    [Abstract] [Full Text] [Related]

  • 59. Blood fluidity is related to the ability to oxidize lipids at exercise.
    Brun JF, Varlet-Marie E, Cassan D, Manetta J, Mercier J.
    Clin Hemorheol Microcirc; 2004 Jun; 30(3-4):339-43. PubMed ID: 15258364
    [Abstract] [Full Text] [Related]

  • 60. Sclerodermatous changes of face, neck and scalp associated with familial porphyria cutanea tarda.
    Thomas CL, Badminton MN, Rendall JR, Anstey AV.
    Clin Exp Dermatol; 2008 Jul; 33(4):422-4. PubMed ID: 18498414
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.